slides · global inventory
Monroes Sequence
Arc collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 33,236
Current window 12,391-12,420
Pages 1,108
Rows per page 30
Arc
12,391-12,420 of 33,236
27
Bausch Health Companies | Results Presentation Deck | 79 slidesBausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · ActionLoop · Why Now1 hit
28
Uses a timeline-like flow diagram to show paths forward from 3Q21.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · ActionLoop · Why Now1 hit
29
The slide uses a dual-track timeline approach, separating 'Internal Organizational Design / Structure' from 'Capital Structure' events.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · ActionLoop · Why Now1 hit
30
Includes a footnote regarding the appointment status of the individuals.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · ActionLoop · Why Now1 hit
31
Bausch Health Companies | Results Presentation Deck | 79 slidesBausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
32
The slide uses a flow diagram to show how business lines were re-categorized under the new corporate structure.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
33
The slide uses a bridge-style table to show how reported figures were adjusted to restated figures.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
34
The slide uses specific CAGR ranges to communicate growth expectations.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
35
The slide uses a three-column layout to categorize updates by business unit.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
36
LOE = Loss of Exclusivity. Data shows significant revenue and profit declines for most units, with Salix being an exception.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
37
LOE = Loss of Exclusivity. Data shows significant revenue and profit declines across all business units due to patent expirations.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
38
LOE stands for Loss of Exclusivity. The table shows revenue and profit figures in millions of dollars.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
39
The table tracks inventory levels and period-over-period changes for specific business units.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
40
The slide highlights a 2% organic revenue decline for the segment. Includes detailed footnotes regarding non-GAAP metrics and segment reporting.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
41
Includes non-GAAP metrics like EBITA and organic growth.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
42
Includes non-GAAP metrics and segment-specific performance data.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
43
Includes a callout highlighting 35% organic revenue growth for Global Solta.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
44
The slide highlights a 6% decline in WELLBUTRIN/APLENZIN revenue as a key driver.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
45
The table compares Q1 2021 vs Q1 2020 performance with reported and constant currency variance metrics.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
46
The table tracks quarterly revenue in millions of dollars for the top 10 products ranked by 1Q21 performance.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
47
The table tracks revenue in millions of dollars for the top 10 products, ranked by 1Q21 performance.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
48
The table lists products by rank and provides quarterly revenue figures in millions of dollars.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
49
The table tracks revenue in millions of dollars for 10 products from 1Q20 to 1Q21.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
50
The table lists products by rank and provides revenue figures in millions of dollars for each of the last five quarters.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
51
The table lists products ranked by revenue in 1Q21, with historical data for the previous four quarters.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
52
The table details specific line items like amortization, impairments, and restructuring costs, showing their impact on both total income and EPS.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
53
Includes a callout box clarifying that corporate G&A and R&D are not allocated.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
54
Includes footnotes regarding segment reporting and estimates.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
55
The slide includes two distinct tables: one for Revenue and one for Adj. Segment Profit/EBITA. It also includes a disclaimer about G&A and R&D allocation.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
56
The slide provides supplemental financial metrics including R&D, G&A, Depreciation, CapEx, and Stock-Based Compensation.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit